Ovarian Cancer Drug Shows Promise With Move To Phase 3 Trial
Links shared publicly online about this topic.
- 737total visits
Ovarian Cancer Drug Shows Promise With Move To Phase 3 Trial
View full resource at medicalnewstoday.com
Tags: Circulation, Cancer, Cancer Medication, Ovarian Cancer, Drug, Phase 3 Clinical Trial, Women's Health
Most Recently Shared on November 12, 2010 at 2:02 pm By:
Ovarian Cancer Drug Shows Promise With Move To Phase 3 Trial: A new drug designed to arrest cancer cell growth b... http://mnt.to/f/3MmS
Also Shared By:
Late-stage ovarian cancer therapy shows promise in phase II trial
medicalxpress.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ...” View full resource at medicalxpress.com
Most Recently Shared on August 3, 2011 at 6:10 pm By:
PhysOrg Health News Health News
Late-stage ovarian cancer therapy shows promise in phase II trial http://tw.medicalxpress.com/231598840
Late-Stage Ovarian Cancer Therapy Shows Promise In Phase II Trial
medicalnewstoday.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conduc” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2011 at 8:05 am By:
MNT Clinical Trials Health News
Late-Stage Ovarian Cancer Therapy Shows Promise In Phase II Trial http://mnt.to/3YHH #clinicaltrials
Ovarian Cancer Drug AMG 386 Shows Promise With Move To Phase 3 Trials In Australia, Canada & Europe « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Ovarian Cancer Drug AMG 386 Shows Promise With Move To Phase 3 Trials In Australia, Canada & Europe « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on November 12, 2010 at 9:27 pm By:
Paul Cacciatore Patient Advocate
Ovarian Cancer Drug AMG 386 Shows Promise With Move To Phase 3 Trials In Australia, Canada & Europe: http://wp.me/pcE2v-1iP
Investigational Ovarian Cancer Drug Shows Promise Against Platinum Resistant Disease
medicalnewstoday.com — “A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group” View full resource at medicalnewstoday.com
Most Recently Shared on October 12, 2010 at 12:05 pm By:
Investigational Ovarian Cancer Drug Shows Promise Against Platinum Resistant Disease http://mnt.to/3L3s #genetics
Investigational ovarian cancer drug shows promise against platinum resistant disease
physorg.com — “A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reported.” View full resource at physorg.com
Most Recently Shared on October 10, 2010 at 10:08 am By:
Investigational ovarian cancer drug shows promise against platinum resistant disease http://bit.ly/cZ4z3q
Advertisement
MNT Ovarian Cancer
@mnt_ovariancanc
Investigational Ovarian Cancer Drug Shows Promise Against Platinum Resistant Disease http://mnt.to/3L3s #ovariancancer
1 year ago...